Disclosures for "Samelisant (SUVN-G3031) for the Treatment of Cataplexy in Patients With Narcolepsy Type-one: Rationale and Study Design of a Phase-two Study"
-
Pradeep Jayarajan has received personal compensation for serving as an employee of Suven Life Sciences Ltd. Pradeep Jayarajan has stock in Suven Life Sciences. Pradeep Jayarajan has received intellectual property interests from a discovery or technology relating to health care.
-
Vinod Goyal has received intellectual property interests from a discovery or technology relating to health care.
-
Anil Shinde has received intellectual property interests from a discovery or technology relating to health care.
-
Satish Jetta has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Palacharla has stock in Suven Life Sciences Limited. Mr. Palacharla has received intellectual property interests from a discovery or technology relating to health care.
-
Vijay Benade has nothing to disclose.
-
Mr. Abraham has nothing to disclose.
-
Mr. Pandey has nothing to disclose.
-
Mr. S has nothing to disclose.
-
Mr. Mohammed has nothing to disclose.
-
Dr. Nirogi has nothing to disclose.